BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38012650)

  • 1. Ginseng-derived nanoparticles reprogram macrophages to regulate arginase-1 release for ameliorating T cell exhaustion in tumor microenvironment.
    Lv Y; Li M; Weng L; Huang H; Mao Y; Yang DA; Wei Q; Zhao M; Wei Q; Rui K; Han X; Fan W; Cai X; Cao P; Cao M
    J Exp Clin Cancer Res; 2023 Nov; 42(1):322. PubMed ID: 38012650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment.
    Han X; Wei Q; Lv Y; Weng L; Huang H; Wei Q; Li M; Mao Y; Hua D; Cai X; Cao M; Cao P
    Mol Ther; 2022 Jan; 30(1):327-340. PubMed ID: 34450250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
    Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
    J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginase-1+ Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression.
    Azambuja JH; Ludwig N; Yerneni SS; Braganhol E; Whiteside TL
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32498400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liposome nanoparticles for targeted delivery of parthenolide induce colorectal cancer necroptosis to ameliorate tumor-infiltrating T cell exhaustion in mice].
    Yao W; Wang X; Yang Y; You J; Jin J; Zeng P; Han Q; Yao X; Sun X; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1674-1681. PubMed ID: 37933642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting sphingosine 1-phosphate receptor 3 inhibits T-cell exhaustion and regulates recruitment of proinflammatory macrophages to improve antitumor efficacy of CAR-T cells against solid tumor.
    Gao G; Liao W; Shu P; Ma Q; He X; Zhang B; Qin D; Wang Y
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37591632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade.
    Aaboe Jørgensen M; Ugel S; Linder Hübbe M; Carretta M; Perez-Penco M; Weis-Banke SE; Martinenaite E; Kopp K; Chapellier M; Adamo A; De Sanctis F; Frusteri C; Iezzi M; Zocca MB; Hargbøll Madsen D; Wakatsuki Pedersen A; Bronte V; Andersen MH
    Cancer Immunol Res; 2021 Nov; 9(11):1316-1326. PubMed ID: 34518197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8
    Zhang Md J; Zhang Md L; Yang Md Y; Liu Md Q; Ma Md H; Huang Md A; Zhao Md Y; Xia Md Z; Liu Md T; Wu Md G
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1533-1546. PubMed ID: 33238192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model.
    Lutz V; Hellmund VM; Picard FSR; Raifer H; Ruckenbrod T; Klein M; Bopp T; Savai R; Duewell P; Keber CU; Weigert A; Chung HR; Buchholz M; Menke A; Gress TM; Huber M; Bauer C
    Cancer Immunol Res; 2023 Apr; 11(4):421-434. PubMed ID: 36758176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.
    Weis-Banke SE; Lisle TL; Perez-Penco M; Schina A; Hübbe ML; Siersbæk M; Holmström MO; Jørgensen MA; Marie Svane I; Met Ö; Ødum N; Madsen DH; Donia M; Grøntved L; Andersen MH
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36316062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
    Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
    Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
    Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase 1 is a key driver of immune suppression in pancreatic cancer.
    Menjivar RE; Nwosu ZC; Du W; Donahue KL; Hong HS; Espinoza C; Brown K; Velez-Delgado A; Yan W; Lima F; Bischoff A; Kadiyala P; Salas-Escabillas D; Crawford HC; Bednar F; Carpenter E; Zhang Y; Halbrook CJ; Lyssiotis CA; Pasca di Magliano M
    Elife; 2023 Feb; 12():. PubMed ID: 36727849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling YWHAH: A potential therapeutic target for overcoming CD8
    Li Q; Yuan Z; Wang Y; Zhai P; Wang J; Zhang C; Shao Z; Xing C
    Int Immunopharmacol; 2024 Jun; 135():112317. PubMed ID: 38796965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
    Glöckner HJ; Martinenaite E; Landkildehus Lisle T; Grauslund J; Ahmad S; Met Ö; Thor Straten P; Hald Andersen M
    Oncoimmunology; 2024; 13(1):2318053. PubMed ID: 38404966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion.
    Li F; Wang Y; Chen D; Du Y
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8
    Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX
    J Hepatol; 2024 May; ():. PubMed ID: 38759889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.